Westwater Resources Announces Positive Lithium Results at Sal Rica
Sep 18, 2017 12:01 pm UTC| Business
CENTENNIAL, Colo., Sept. 18, 2017 -- Westwater Resources, Inc. (Nasdaq:WWR) (ASX:URI), an energy metals exploration and development company, is pleased to announce positive lithium shallow brine assay results from its...
IGC Readies Line of Medical Dispensary Products Targeting Alzheimer’s Disease Based on Novel Data
Sep 18, 2017 12:01 pm UTC| Business
BETHESDA, Md., Sept. 18, 2017 -- India Globalization Capital, Inc. (NYSE-MKT:IGC) provides an update on compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model,...
Sep 18, 2017 12:01 pm UTC| Business
Independent Data Monitoring Committee Conducts Phase 1 Safety Review and Unanimously Recommends Opening of Phase 2 Enrollment First Seven Subjects Receiving ProTmune Clear Phase 1 Safety Objectives of Engraftment and...
ABcann Global Receives $11.9 Million from Exercise of Warrants
Sep 18, 2017 12:01 pm UTC| Business
NAPANEE, Ontario, Sept. 18, 2017 -- ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) is pleased to announce that it has received total proceeds of $11,895,298 from the exercise of an aggregate of...
Qorvo® Expands Presence in Defense Market with Veteran-Owned U.S. Distributor
Sep 18, 2017 12:01 pm UTC| Business
GREENSBORO, N.C., Sept. 18, 2017 -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, today announced that it has entered into a channel partnership with Veterans Trading...
Sep 18, 2017 12:01 pm UTC| Business
Preclinical Research Demonstrating a Direct Relationship Between Misfolded Light Chain Toxicity and NT-proBNP ProductionClinical Outcomes Research Showing a Correlation between NT-proBNP Response and Health-related Quality...
Achaogen Adds Liz Bhatt as Chief Business Officer
Sep 18, 2017 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2017 -- Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections,...